Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:

Refractive IOL Market On Track To Approach $1 Bil. By 2010, AMO Asserts

This article was originally published in The Gray Sheet

  • News

Executive Summary

Advanced Medical Optics projects the worldwide refractive intraocular lens market will reach $180 mil.-$200 mil. this year and approach $1 bil. by 2010, based on accelerating uptake of the technology

You may also be interested in...



Alcon, AMO Try DTC Ads To Accelerate Presbyopia IOL Market Growth

Alcon is testing a direct-to-consumer advertising campaign to help accelerate adoption of its AcrySof ReStor multifocal intraocular lens (IOL) for presbyopia, according to the firm

Alcon, AMO Try DTC Ads To Accelerate Presbyopia IOL Market Growth

Alcon is testing a direct-to-consumer advertising campaign to help accelerate adoption of its AcrySof ReStor multifocal intraocular lens (IOL) for presbyopia, according to the firm

Advanced Medical Optics And Alcon Leave Courtroom Behind

Advanced Medical Optics and Alcon, facing the prospect of long-term litigation costs, settled all of their outstanding patent disputes relating to ophthalmic surgery July 10 in an agreement where Alcon will pay AMO $121 mil

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight
Medtech Insight
Tags:
UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By